Boots Dry Cough & Congestion Relief oral solution

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Pseudoephedrine hydrochloride; Dextromethorphan hydrobromide

Available from:

The Boots Company Plc

ATC code:

R01BA52

INN (International Name):

Pseudoephedrine hydrochloride; Dextromethorphan hydrobromide

Dosage:

6mg/1ml ; 2mg/1ml

Pharmaceutical form:

Oral solution

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 03090200

Patient Information leaflet

INFORMATION FOR THE USER
Boots Dry Cough & Congestion Relief Oral Solution
Almus Dry Cough Linctus with Decongestant
(Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride)
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
This medicine is available without prescription to treat minor
conditions.
However, you still need to take it carefully to get the best results
from it.

Keep this leaflet, you may need to read it again

Ask your pharmacist if you need more information or advice
WHAT THIS MEDICINE IS FOR
This medicine contains Dextromethorphan, a cough suppressant, which
acts to reduce coughing. It
also contains Pseudoephedrine, a decongestant, which acts to relieve a
blocked nose.
It can be used to relieve symptoms of dry and tickly coughs, blocked
sinuses and catarrh. Dry coughs
do not produce phlegm or mucus on the chest.
For children, simple treatments should be tried first before you give
this medicine. Further
information on “TREATING COUGHS AND COLDS IN CHILDREN” is provided
at the end of this leaflet.
BEFORE YOU TAKE THIS MEDICINE
This medicine can lead to dependence. Therefore the treatment should
be of short duration.
Talk to your pharmacist before taking this medicine if you:

are or have ever been addicted to opioids, alcohol, prescription
medicines, or illegal drugs.

have previously suffered from withdrawal symptoms such as agitation,
anxiety, shaking or
sweating, when you have stopped taking alcohol or drugs.
Taking this medicine regularly, particularly for a long time, can lead
to addiction. Only use this
medicine as described in the leaflet.
Addiction can cause withdrawal symptoms when you stop taking this
medicine. Withdrawal
symptoms can include restlessness, difficulty sleeping, irritability,
agitation, anxiety, feeling your
heartbeat (palpitations), increased blood pressure, feeling or being
sick, diarrhoea, loss of appetite,
shaking, shivering or sweating. Speak to your doctor if you experience
withdrawal symptoms.
This medicine ca

Summary of Product characteristics

1
NAME OF THE MEDICINAL PRODUCT
Boots Dry Cough & Congestion Relief Oral Solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient Mg/5ml
Pseudoephedrine hydrochloride 30.0
Dextromethorphan hydrobromide 10.0
3
PHARMACEUTICAL FORM
Oral Solution.
A clear, yellow, viscous liquid.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cough suppressant for the relief of acute non-productive cough
associated with upper
respiratory tract infection. Decongestant for the relief of catarrh
and blocked sinuses
associated with nasal congestion and congestion of mucous membranes of
the upper
respiratory tract associated with the common cold.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults and children over 12 years: two 5ml spoonfuls to be taken three
times a day.
Elderly: the normal adult dose is appropriate in the elderly.
Children 6-12 years: one 5ml spoonful to be taken three times a day.
This medicine is contraindicated in children under 6 years of age (see
section 4.3).
Children of 6-12 years of age: not to be used for more than 5 days
without the advice of a
doctor. Parents and carers should seek medical attention if the
child's condition deteriorates
during treatment.
Warning: Do not exceed the stated dose.
Keep out of the sight and reach of children.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substances or any of the excipients.
Severe renal impairment
Cardiovascular disease including hypertension and peripheral vascular
disease
Diabetes mellitus
Phaeochromocytoma
Hyperthyroidism
Closed angle glaucoma
Prostatic enlargement
Patients with chronic or persistent cough such as occurs with asthma,
if you are suffering
from an acute asthma attack, or where cough is accompanied by
excessive secretions.
Dextromethorphan should not be given to subjects in, or at risk of
developing respiratory
failure.
Patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days
of stopping such
treatment (see section 4.5).
Patients taking selective serotonin reuptake inhibitors (SSRIs, see
section 4.5).
Beta-bloc